Skip to main content
. Author manuscript; available in PMC: 2023 Oct 10.
Published in final edited form as: J Rheumatol. 2019 Apr 1;47(3):431–440. doi: 10.3899/jrheum.180233

Table 1B.

Baseline characteristics: clinical examination.

Clinical Factors (subset n = 101) First Followup Visit 6-month Visit
Full Sample Nonresponder Responder Nonresponder Responder
Frequency (%) N Frequency (%) N Frequency (%) N Frequency (%) N Frequency (%)
Previous ligament/meniscus injuries
 No 75 (74.3) 23 11 (47.8) 78 64 (82.1) 79 58 (73.4) 22 17 (77.3)
 Yes 26 (25.7) 23 12 (52.2) 78 14 (18.0) 79 21 (26.6) 22 5 (22.7)
Crepitus
 Absent 6 (5.9) 23 2 (8.7) 78 4 (5.1) 79 5 (6.3) 22 1 (4.6)
 Audible and/or palpable 95 (94.1) 23 21 (91.3) 78 74 (94.9) 79 74 (93.7) 22 21 (95.5)
Quadriceps muscle wasting
 Absent 29 (28.7) 23 9 (39.1) 78 20 (25.6) 79 25 (31.7) 22 4 (18.2)
 Possible 18 (17.8) 23 1 (4.4) 78 17 (21.8) 79 13 (16.5) 22 5 (22.7)
 Present 54 (53.5) 23 13 (56.5) 78 41 (52.6) 79 41 (51.9) 22 13 (59.1)
Bony enlargement
 Absent 54 (53.5) 23 10 (43.5) 78 44 (56.4) 79 40 (50.6) 22 14 (63.6)
 Unsure 7 (6.9) 23 12 (52.2) 78 28 (35.9) 79 33 (41.8) 22 7 (31.8)
 Present 40 (39.6) 23 1 (4.4) 78 6 (7.7) 79 6 (7.6) 22 1 (4.6)
Anserine tenderness
 Absent 76 (75.3) 23 21 (91.3) 78 55 (70.5) 79 60 (76.0) 22 16 (72.7)
 Present 25 (24.8) 23 2 (8.7) 78 23 (29.5) 79 19 (24.1) 22 6 (27.3)
Patellofemoral tenderness
 Absent 59 (58.4) 23 18 (78.3) 78 41 (52.6) 79 46 (58.2) 22 13 (59.1)
 Present 42 (41.6) 23 5 (21.7) 78 37 (47.4) 79 33 (41.8) 22 9 (40.9)
Tibiofemoral tenderness
 Absent 44 (43.6) 23 16 (69.6) 78 28 (35.9) 79 37 (46.8) 22 7 (31.8)
 Medial tibiofemoral joint 10 (9.9) 23 2 (8.7) 78 8 (10.3) 79 6 (7.6) 22 4 (18.2)
 Lateral tibiofemoral joint 31 (30.7) 23 3 (13.0) 78 28 (35.9) 79 25 (31.7) 22 6 (27.3)
 Medial and lateral tibiofemoral joint 16 (15.8) 23 2 (8.7) 78 14 (18.0) 79 11 (13.9) 22 5 (22.7)
Ballottement*
 Absent 77 (76.2) 23 15 (65.2) 78 62 (79.5) 79 57 (72.2) 22 20 (90.9)
 Present with or without click 24 (23.8) 23 8 (34.8) 78 16 (20.5) 79 22 (27.9) 22 2 (9.1)
Bulge sign¥
 0 35 (34.7) 23 7 (30.4) 78 28 (35.9) 79 27 (34.2) 22 8 (36.4)
 Trace 35 (34.7) 23 7 (30.4) 78 28 (35.9) 79 27 (34.2) 22 8 (36.4)
 1 16 (15.8) 23 4 (17.4) 78 12 (15.4) 79 14 (17.7) 22 2 (9.1)
 2 12 (11.9) 23 4 (17.4) 78 8 (10.3) 79 9 (11.4) 22 3 (13.6)
 3 3 (3.0) 23 1 (4.4) 78 2 (2.6) 79 2 (2.5) 22 1 (4.6)

Values are frequency (%) unless otherwise specified.

Clinical tests were performed in a subset of 103 patients only; 2 patients did not complete KOOS.

*

Ballottement test defined as positive click/tap or downward movement of the patella on pressure and rebounding of patella upon removal of pressure.

¥

0 = no wave produced on down stroke; trace = a small wave on medial side with down stroke; 1 = larger bulge on medial side with down stroke; 2 = spontaneously returned to medial side after upstroke; 3 = so much fluid that it was not possible to move the effusion out of the medial aspect of the knee. KOOS: Knee Injury and Osteoarthritis Outcome Score.